This site is intended for healthcare professionals
FDA Hero  Banner - Multi-coloured pills and tablets
FDA Drug information

Clindamycin Phosphate and Benzoyl Peroxide

Read time: 1 mins
Marketing start date: 27 Apr 2024

Summary of product characteristics


Effective Time

20220804

Version

3

Spl Product Data Elements

Clindamycin Phosphate and Benzoyl Peroxide Clindamycin Phosphate and Benzoyl Peroxide CLINDAMYCIN PHOSPHATE CLINDAMYCIN BENZOYL PEROXIDE BENZOYL PEROXIDE CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) DIMETHICONE DISODIUM LAURYL SULFOSUCCINATE EDETATE SODIUM GLYCERIN METHYLPARABEN POLOXAMER 182 WATER SILICON DIOXIDE SODIUM HYDROXIDE WHITE TO OFF-WHITE

Application Number

ANDA210794

Brand Name

Clindamycin Phosphate and Benzoyl Peroxide

Generic Name

Clindamycin Phosphate and Benzoyl Peroxide

Product Ndc

70771-1450

Product Type

HUMAN PRESCRIPTION DRUG

Route

TOPICAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1450-4 Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5% Rx only 45 g Clindamycin and benzoyl paroxide gel carton label

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.